NDC 63304-979-04 - Amoxicillin and clavulanate potassium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63304-979
- Requested NDC
- 63304-979-04
- Package NDCs from labels
- 63304-979-03, 63304-979-01, 63304-979-04
- Manufacturer
- Ranbaxy Pharmaceuticals Inc.
- Effective date
- 2008-05-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Amoxicillin and clavulanate potassium - Ranbaxy Pharmaceuticals Inc. | Ranbaxy Pharmaceuticals Inc. | 2008-05-01 | HUMAN PRESCRIPTION DRUG LABELING |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63304-979-01 | Amoxicillin and clavulanate potassium | 75 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 75 | 1 | |
| 63304-979-03 | Amoxicillin and clavulanate potassium | 50 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 50 | 1 | |
| 63304-979-04 | Amoxicillin and clavulanate potassium | 100 mL in 1 BOTTLE | POWDER, FOR SUSPENSION | 100 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63304-979 | AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN AND CLAVULANATE POTASSIUM) POWDER, FOR SUSPENSION AMOXICILLIN AND CLAVULANATE POTASSIUM (AMOXICILLIN AND CLAVULANATE POTASSIUM) TABLET, CHEWABLE [RANBAXY PHARMACEUTICALS INC.] | 1 | 3 package rows | 20080602_b897c800-24a2-4e76-8668-498c5515c3d0.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63304-979-01 | ML - Milliliter | 63304-979 | f3afe026-6bcd-4b2c-a8e1-72f546d6f072 | 1 | 2013-02-13 |
| 63304-979-03 | ML - Milliliter | 63304-979 | 17af81a3-924c-4fe6-9550-8977b064f0aa | 1 | 2013-02-13 |
| 63304-979-04 | ML - Milliliter | 63304-979 | caadf23d-ef90-47eb-ab56-47fcbccf82eb | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | 2718248d-d948-466e-959b-1a972519f108 | 2024-05-14 | Warnings, Adverse reactions | 617430 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | 61f9224b-a91b-4154-a7f3-22c14601230f | 2023-10-31 | Warnings, Adverse reactions | 617423 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | A-S Medication Solutions | 029a49f2-2132-4160-a0d6-2d108a456a22 | 2023-03-02 | Warnings, Adverse reactions | 617430 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Proficient Rx LP | 5db8df09-4e06-4681-918d-29ca6b50b3ec | 2022-05-02 | Warnings, Adverse reactions | 617430 |
| Amoxicillin and Clavulanate Potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Proficient Rx LP | 4655e0ea-f7d5-4f7c-bf7b-266337bc05b8 | 2019-11-01 | Warnings, Adverse reactions | 617430 |
| amoxicillin and clavulanate potassium | AMOXICILLIN AND CLAVULANATE POTASSIUM | Proficient Rx LP | 1f252ad3-373c-4a6d-96e7-53ba820d201b | 2019-11-01 | Warnings, Adverse reactions | 617430 |
| 21209BCF-E831-B3D6-7F05-992BFCDE3889 | b897c800-24a2-4e76-8668-498c5515c3d0 | 2008-05-01 | Warnings, Adverse reactions | 21209BCF-E831-B3D6-7F05-992BFCDE3889 b897c800-24a2-4e76-8668-498c5515c3d0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.